Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates
VOQUEZNA® (vonoprazan) tablets approved by the U.S. Food and Drug Administration (FDA) for the treatment of Erosive GERD and relief...
Clinical Trial
BioSyent Schedules Q3 and YTD 2023 Earnings Release for November 16, 2023
MISSISSAUGA, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its...
PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights
Updated data from Phase 1 PYNNACLE clinical trial of PC14586 presented at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and...
Aeterna Zentaris Reports Third Quarter 2023 Financial Results
- Launch of Ghryvelin™ in a number of key countries in the European Economic Area - Approval of Macrilen® in...
Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS
-- Blocking of α5β1 integrin has been shown to improve motor function and increase survival in the SOD1G93A mouse model of...
AlzeCure Publishes its Interim Report for January – September 2023
STOCKHOLM, SWEDEN / ACCESSWIRE / November 9, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced...
Angle PLC Announces Trading and Business Update
Revenue recognised for 2023 expected to be up 120% at c. £2.2 million with sales secured in 2023 expected to...
Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies
ANGLE LAUNCHES PD-L1 TEST TO SUPPORT CANCER THERAPY STUDIESANGLE's Portrait PD-L1 test uses CTCs harvested from the Parsortix system to...
Former Amryt Pharma Leadership Team join Poolbeg
Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg PharmaPoolbeg team boosted by highly experienced executives with track...
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023
Reports Net Revenues of $180.6 Million for the Three Months Ended September 30, 2023RANCHO CUCAMONGA, CA / ACCESSWIRE / November...
Medidata Announces New Data Integration Solutions to Accelerate Clinical Trials: Clinical Data Studio and Health Record Connect
Adding to Medidata’s already extensive platform, Medidata Clinical Data Studio and Medidata Health Record Connect usher in a new era...
Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq’s Bid Price Rule
SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced...
Neuroscientist and NervGen Pharma Scientific Founder, Dr. Jerry Silver, Interviewed on ‘Remarkable People’ Podcast Hosted by Tech Luminary Guy Kawasaki
Dr. Silver's life work, culminating in NervGen's NVG-291, is currently in a Phase 1b/2a clinical trial for individuals with spinal...
Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
Click here to register for November 14 investor webcastCompany plans to file its Earnings Report on November 14, 2023 on...
New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis
People living with treatment-resistant active psoriatic arthritis reported meaningful improvements in pain, physical function and fatigue on guselkumab through six...
Autonomix Medical, Inc. Launches Social Media Channels
Company developing innovative two-fold technology designed to both detect the neural signals relating to pain or disease and ablate them...
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
CARMEL, Ind., Nov. 08, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
PharmAla Partners with Clariti Strategic Advisors™
Clariti to be PharmAla’s exclusive Long-Term Strategic Advisory and Investment Banking PartnerVANCOUVER, British Columbia, Nov. 08, 2023 (GLOBE NEWSWIRE) --...
Parexel Named 2023 Healthcare Businesswomen’s Association ACE Award Honoree
Award reflects company’s ongoing commitment to advancing women in leadership and maintaining a gender-equitable cultureDURHAM, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE)...
AIM ImmunoTech Announces Encouraging Translational Data from Phase 2 Study Evaluating Ampligen® for the Treatment of Advanced Recurrent Ovarian Cancer
Data presented at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting Longitudinal comparison of biomarkers in tumor microenvironment...